Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VERV | OABI | TBPH | ||
| Company | Verve Therapeutics Inc | Omniab Inc | Theravance Bio Ord | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.12 | 3.50 | 9.65 | ||
| High | 5.76 | 3.68 | 9.83 | ||
| Low | 5.12 | 3.50 | 9.56 | ||
| Last | 5.74 | 3.50 | 9.59 | ||
| Change | +0.58 | unch | -0.14 | ||
| % Change | +11.24% | unch | -1.44% | ||
| Volume | 3,819,400 | 903,600 | 310,200 | ||
| 20-Day Average Volume | 1,760,410 | 484,890 | 217,060 | ||
| Previous Close | 5.16 | 3.50 | 9.73 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.97 | 3.87 | 9.70 | ||
| 20-Day Raw Stochastic | 39.24% | 8.97% | 40.54% | ||
| 20-Day Relative Strength | 49.75% | 37.04% | 52.89% | ||
| Weighted Alpha | -51.72 | -41.56 | -4.15 | ||
| Today's Opinion | Hold | 100% Sell | 72% Buy | ||
| Previous Opinion | 32% Sell | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 72% Sell | 100% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 12/13/24 | -7.65% since 12/13/24 | -2.94% since 12/13/24 | ||
| Low | 4.88 on 12/19/24 | 3.43 on 12/19/24 | 9.56 on 12/20/24 | ||
| High | 5.76 on 12/20/24 | 3.95 on 12/16/24 | 10.08 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | +26.15% since 11/20/24 | -10.26% since 11/20/24 | -3.81% since 11/20/24 | ||
| Low | 4.44 on 11/21/24 | 3.43 on 12/19/24 | 9.14 on 12/02/24 | ||
| High | 7.66 on 12/03/24 | 4.21 on 11/26/24 | 10.25 on 12/09/24 | ||
| 3-Month | |||||
| %Chg | +10.60% since 09/20/24 | -20.81% since 09/20/24 | +19.73% since 09/20/24 | ||
| Low | 4.37 on 10/10/24 | 3.43 on 12/19/24 | 7.88 on 10/09/24 | ||
| High | 7.66 on 12/03/24 | 4.87 on 11/06/24 | 10.26 on 11/13/24 | ||
| 6-Month | |||||
| %Chg | +11.89% since 06/20/24 | -13.79% since 06/20/24 | +10.74% since 06/20/24 | ||
| Low | 4.30 on 08/14/24 | 3.43 on 12/19/24 | 7.44 on 08/09/24 | ||
| High | 7.96 on 07/16/24 | 4.96 on 07/26/24 | 10.42 on 07/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 485,971 | 494,256 | 471,579 | ||
| Shares Outstanding, K | 84,664 | 141,216 | 49,174 | ||
| Annual Sales | 11,760,000 | 34,160,000 | 57,420,000 | ||
| Annual Net Income | -200,070,000 | -50,620,000 | -55,190,000 | ||
| Last Quarter Sales | 6,870,000 | 4,170,000 | 16,870,000 | ||
| Last Quarter Net Income | -50,130,000 | -16,370,000 | -12,700,000 | ||
| 60-Month Beta | 1.71 | -0.14 | 0.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 11/05/24 | -0.16 on 11/12/24 | -0.06 on 11/12/24 | ||
| Latest Earnings Date | 11/05/24 | 11/12/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||